Xi An Aogu Biotech Co Ltd

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LABELING1 refused line

  Fair Packaging and Labeling Act

  The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• UNSAFE ADD1 refused line

  Food additive unsafe under section 409

  The product appeared to contain a food additive that is unsafe within the meaning of section 409 of the FD&C Act, the section that governs which food additives may be used and under what conditions.

Questions about Xi An Aogu Biotech Co Ltd

Is Xi An Aogu Biotech Co Ltd on an FDA import alert?

No listing for Xi An Aogu Biotech Co Ltd appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the China page.

Has FDA refused shipments from Xi An Aogu Biotech Co Ltd?

Yes. FDA refused 2 shipment lines from Xi An Aogu Biotech Co Ltd between April 19, 2024 and November 10, 2025. The most recent, on November 10, 2025, was noni (herbal & botanicals, not teas), charged as LABELING (fair packaging and labeling act).

Why did FDA refuse Xi An Aogu Biotech Co Ltd's shipments?

The most frequent charges are LABELING (fair packaging and labeling act, 1 line) and UNAPPROVED (unapproved new drug, 1 line).

What is Xi An Aogu Biotech Co Ltd's FEI number?

Xi An Aogu Biotech Co Ltd's FDA Establishment Identifier (FEI) is 3020188413.